Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 96

1.

Characterization of Novel Injectable Lifting Agents Used in Colonic Polyp Removal: An Emerging Amyloid Mimic.

Pezhouh MK, Burgart LJ, Chiu K, Cohen DA, Hutchings DA, Sanderson SO, Shirazi M, Stanich PP, VandenBussche CJ, Voltaggio L, Willhoit ED, Xue Y, Arnold CA.

Am J Surg Pathol. 2020 Jan 13. doi: 10.1097/PAS.0000000000001435. [Epub ahead of print]

PMID:
31934919
2.

Tubulointerstitial damage and interstitial immune cell phenotypes are useful predictors for renal survival and relapse in antineutrophil cytoplasmic antibody-associated vasculitis.

Bitton L, Vandenbussche C, Wayolle N, Gibier JB, Cordonnier C, Verine J, Humez S, Bataille P, Lenain R, Ramdane N, Azar R, Mac Namara E, Hatron PY, Maurage CA, Perrais M, Frimat M, Vanhille P, Glowacki F, Buob D, Copin MC, Quéméneur T, Gnemmi V.

J Nephrol. 2020 Jan 8. doi: 10.1007/s40620-019-00695-y. [Epub ahead of print]

PMID:
31916228
3.

Performance of novel non-invasive urine assay UroSEEK in cohorts of equivocal urine cytology.

Rodriguez Pena MDC, Springer SU, Taheri D, Li L, Tregnago AC, Eich ML, Eltoum IA, VandenBussche CJ, Papadopoulos N, Kinzler KW, Vogelstein B, Netto GJ.

Virchows Arch. 2019 Sep 3. doi: 10.1007/s00428-019-02654-1. [Epub ahead of print]

PMID:
31482302
4.

Lower Genital Tract Dysplasia in Female Solid Organ Transplant Recipients.

Thimm MA, Rositch AF, VandenBussche C, McDonald L, Garonzik Wang JM, Levinson K.

Obstet Gynecol. 2019 Aug;134(2):385-394. doi: 10.1097/AOG.0000000000003378.

PMID:
31306332
5.

MicroRNA profiling in serous cavity specimens: Diagnostic challenges and new opportunities.

Nicolè L, Cappello F, Cappellesso R, VandenBussche CJ, Fassina A.

Cancer Cytopathol. 2019 Aug;127(8):493-500. doi: 10.1002/cncy.22143. Epub 2019 Jun 2. Review.

PMID:
31154675
6.

Prognostic Value of Microscopic Hematuria after Induction of Remission in Antineutrophil Cytoplasmic Antibodies-Associated Vasculitis.

Vandenbussche C, Bitton L, Bataille P, Glowacki F, Azar R, Hatron PY, Macnamara E, Gheerbrant JD, Cardon G, Hoffmann M, Auxenfants E, Gnemmi V, Quéméneur T.

Am J Nephrol. 2019;49(6):479-486. doi: 10.1159/000500352. Epub 2019 May 22.

PMID:
31117066
7.

A Review of Urine Ancillary Tests in the Era of the Paris System.

Allison DB, VandenBussche CJ.

Acta Cytol. 2020;64(1-2):182-192. doi: 10.1159/000499027. Epub 2019 May 6. Review.

PMID:
31060038
8.

Variability among observers utilizing the CellSolutions BestCyte Cell Sorter imaging system for the assessment of urinary tract cytology specimens.

Gelwan E, Zhang ML, Allison DB, Cowan ML, DeLuca J, Fite JJ, Wangsiricharoen S, Williamson B, Zhou A, VandenBussche CJ.

J Am Soc Cytopathol. 2019 Jan - Feb;8(1):18-26. doi: 10.1016/j.jasc.2018.10.001. Epub 2018 Oct 12.

PMID:
30929755
9.

Cytomorphologic and molecular analyses of fallopian tube fimbrial brushings for diagnosis of serous tubal intraepithelial carcinoma.

Chui MH, Vang R, Wang TL, Shih IM, VandenBussche CJ.

Cancer Cytopathol. 2019 Mar;127(3):192-201. doi: 10.1002/cncy.22110. Epub 2019 Mar 12.

PMID:
30861338
10.

90Y-TheraSpheres: The New Look of Yttrium-90.

Arnold CA, Pezhouh MK, Lam-Himlin D, Pittman ME, VandenBussche C, Voltaggio L.

Am J Surg Pathol. 2019 May;43(5):688-694. doi: 10.1097/PAS.0000000000001223.

PMID:
30720534
11.

Impact of intravesical therapy for non-muscle invasive bladder cancer on the accuracy of urine cytology.

Gupta M, Milbar N, Tema G, Pederzoli F, Chappidi M, Kates M, VandenBussche CJ, Bivalacqua TJ.

World J Urol. 2019 Oct;37(10):2051-2058. doi: 10.1007/s00345-018-02624-3. Epub 2019 Jan 23.

PMID:
30671639
12.

Correction: Non-invasive detection of urothelial cancer through the analysis of driver gene mutations and aneuploidy.

Springer SU, Chen CH, Rodriguez Pena MDC, Li L, Douville C, Wang Y, Cohen JD, Taheri D, Silliman N, Schaefer J, Ptak J, Dobbyn L, Papoli M, Kinde I, Afsari B, Tregnago AC, Bezerra SM, VandenBussche C, Fujita K, Ertoy D, Cunha IW, Yu L, Bivalacqua TJ, Grollman AP, Diaz LA, Karchin R, Danilova L, Huang CY, Shun CT, Turesky RJ, Yun BH, Rosenquist TA, Pu YS, Hruban RH, Tomasetti C, Papadopoulos N, Kinzler KW, Vogelstein B, Dickman KG, Netto GJ.

Elife. 2018 Nov 12;7. pii: e43237. doi: 10.7554/eLife.43237.

13.

CD24 regulates cancer stem cell (CSC)-like traits and a panel of CSC-related molecules serves as a non-invasive urinary biomarker for the detection of bladder cancer.

Ooki A, VandenBussche CJ, Kates M, Hahn NM, Matoso A, McConkey DJ, Bivalacqua TJ, Hoque MO.

Br J Cancer. 2018 Oct;119(8):961-970. doi: 10.1038/s41416-018-0291-7. Epub 2018 Oct 17.

14.

Nodular fasciitis of the parotid gland: A challenging diagnosis on FNA.

Allison DB, VandenBussche CJ, Rooper LM, Wakely PE, Rossi ED, Faquin WC, Ali SZ.

Cancer Cytopathol. 2018 Oct;126(10):872-880. doi: 10.1002/cncy.22049. Epub 2018 Oct 12.

15.

A comprehensive overview of genomic imprinting in breast and its deregulation in cancer.

Goovaerts T, Steyaert S, Vandenbussche CA, Galle J, Thas O, Van Criekinge W, De Meyer T.

Nat Commun. 2018 Oct 8;9(1):4120. doi: 10.1038/s41467-018-06566-7. Review.

16.

Molecular genetic alterations in thyroid transcription factor 1-negative lung adenocarcinoma in cytology specimens: A subset with aggressive behavior and a poor prognosis.

Rodriguez EF, VandenBussche CJ, Chowsilpa S, Maleki Z.

Cancer Cytopathol. 2018 Oct;126(10):853-859. doi: 10.1002/cncy.22048. Epub 2018 Sep 10.

17.

cancer of unknown primary: Ancillary testing of cytologic and small biopsy specimens in the era of targeted therapy.

Cowan ML, VandenBussche CJ.

Cancer Cytopathol. 2018 Aug;126 Suppl 8:724-737. doi: 10.1002/cncy.22014. Review.

18.

Evaluation of Sienna Cancer Diagnostics hTERT Antibody on 500 Consecutive Urinary Tract Specimens.

Allison DB, Sharma R, Cowan ML, VandenBussche CJ.

Acta Cytol. 2018;62(4):302-310. doi: 10.1159/000489181. Epub 2018 Jun 6.

19.

A 20-year and 46,000-specimen journey to Paris reveals the influence of reporting systems and passive peer feedback on pathologist practice patterns.

VandenBussche CJ, Allison DB, Gupta M, Ali SZ, Rosenthal DL.

Cancer Cytopathol. 2018 Jun;126(6):381-389. doi: 10.1002/cncy.22006. Epub 2018 May 14.

20.

Urinary cytology and the Paris system for reporting urinary cytology: Implications for urological management.

Gupta M, VandenBussche CJ, Bivalacqua TJ.

Cytopathology. 2018 Aug;29(4):368-370. doi: 10.1111/cyt.12538. Epub 2018 Mar 25.

PMID:
29575439
21.

Non-invasive detection of urothelial cancer through the analysis of driver gene mutations and aneuploidy.

Springer SU, Chen CH, Rodriguez Pena MDC, Li L, Douville C, Wang Y, Cohen JD, Taheri D, Silliman N, Schaefer J, Ptak J, Dobbyn L, Papoli M, Kinde I, Afsari B, Tregnago AC, Bezerra SM, VandenBussche C, Fujita K, Ertoy D, Cunha IW, Yu L, Bivalacqua TJ, Grollman AP, Diaz LA, Karchin R, Danilova L, Huang CY, Shun CT, Turesky RJ, Yun BH, Rosenquist TA, Pu YS, Hruban RH, Tomasetti C, Papadopoulos N, Kinzler KW, Vogelstein B, Dickman KG, Netto GJ.

Elife. 2018 Mar 20;7. pii: e32143. doi: 10.7554/eLife.32143. Erratum in: Elife. 2018 Nov 12;7:.

22.

Lessons learned from 29 lymphoepithelial cysts of the pancreas: institutional experience and review of the literature.

Groot VP, Thakker SS, Gemenetzis G, Noë M, Javed AA, Burkhart RA, Noveiry BB, Cameron JL, Weiss MJ, VandenBussche CJ, Fishman EK, Hruban RH, Wolfgang CL, Lennon AM, He J.

HPB (Oxford). 2018 Jul;20(7):612-620. doi: 10.1016/j.hpb.2018.01.003. Epub 2018 Mar 9. Review.

23.

Arsenic promotes the COX2/PGE2-SOX2 axis to increase the malignant stemness properties of urothelial cells.

Ooki A, Begum A, Marchionni L, VandenBussche CJ, Mao S, Kates M, Hoque MO.

Int J Cancer. 2018 Jul 1;143(1):113-126. doi: 10.1002/ijc.31290. Epub 2018 Feb 14.

24.

Tacrolimus-induced nephrotoxicity in mice is associated with microRNA deregulation.

Vandenbussche C, Van der Hauwaert C, Dewaeles E, Franczak J, Hennino MF, Gnemmi V, Savary G, Tavernier Q, Nottet N, Paquet A, Perrais M, Blum D, Mari B, Pottier N, Glowacki F, Cauffiez C.

Arch Toxicol. 2018 Apr;92(4):1539-1550. doi: 10.1007/s00204-018-2158-3. Epub 2018 Jan 23.

PMID:
29362864
25.

When words matter: A "suspicious" urinary tract cytology diagnosis improves patient follow-up among nonurologists.

Fite JJ, Rosenthal DL, VandenBussche CJ.

Cancer Cytopathol. 2018 Apr;126(4):282-288. doi: 10.1002/cncy.21971. Epub 2018 Jan 23.

26.

Fine-needle aspiration of a pancreatic neuroendocrine tumor with prominent rhabdoid features.

Fite JJ, Ali SZ, VandenBussche CJ.

Diagn Cytopathol. 2018 Jul;46(7):600-603. doi: 10.1002/dc.23892. Epub 2018 Jan 23.

PMID:
29359517
27.

The Paris System for Reporting Urinary Cytology: early review of the literature reveals successes and rare shortcomings.

Cowan ML, VandenBussche CJ.

J Am Soc Cytopathol. 2018 Jul - Aug;7(4):185-194. doi: 10.1016/j.jasc.2018.04.001. Epub 2018 Apr 19. Review.

PMID:
31043275
28.

Paris Interobserver Reproducibility Study (PIRST).

Kurtycz DFI, Barkan GA, Pavelec DM, Rosenthal DL, Wojcik EM, VandenBussche CJ, Mangiulli K, Olson MT.

J Am Soc Cytopathol. 2018 Jul - Aug;7(4):174-184. doi: 10.1016/j.jasc.2018.02.005. Epub 2018 Feb 21.

PMID:
31043274
29.

YAP1 and COX2 Coordinately Regulate Urothelial Cancer Stem-like Cells.

Ooki A, Del Carmen Rodriguez Pena M, Marchionni L, Dinalankara W, Begum A, Hahn NM, VandenBussche CJ, Rasheed ZA, Mao S, Netto GJ, Sidransky D, Hoque MO.

Cancer Res. 2018 Jan 1;78(1):168-181. doi: 10.1158/0008-5472.CAN-17-0836. Epub 2017 Nov 27.

30.

Performance of ovarian cyst fluid fine-needle aspiration cytology.

Zhou AG, Levinson KL, Rosenthal DL, VandenBussche CJ.

Cancer Cytopathol. 2018 Feb;126(2):112-121. doi: 10.1002/cncy.21911. Epub 2017 Aug 21.

31.

The fine needle aspiration of translocation sarcomas.

VandenBussche CJ, Adams CL, McDonald OG, Whitworth SA, Ali SZ.

Cytopathology. 2017 Oct;28(5):356-363. doi: 10.1111/cyt.12446. Epub 2017 Jul 17.

PMID:
28718513
32.

Urinary tract washing specimens containing atypical urothelial tissue fragments are significantly associated with urothelial neoplasia.

Zhang ML, Zhou AG, Rosenthal DL, VandenBussche CJ.

Diagn Cytopathol. 2017 Sep;45(9):795-799. doi: 10.1002/dc.23767. Epub 2017 Jun 9.

PMID:
28597510
33.

Digital image analysis supports a nuclear-to-cytoplasmic ratio cutoff value of 0.5 for atypical urothelial cells.

Hang JF, Charu V, Zhang ML, VandenBussche CJ.

Cancer Cytopathol. 2017 Sep;125(9):710-716. doi: 10.1002/cncy.21883. Epub 2017 Jun 5.

34.

Upper urinary tract washings outperform voided urine specimens to detect upper tract high-grade urothelial carcinoma.

Zhang ML, Rosenthal DL, VandenBussche CJ.

Diagn Cytopathol. 2017 Aug;45(8):700-704. doi: 10.1002/dc.23746. Epub 2017 May 28.

PMID:
28556525
35.

Alternative lengthening of telomeres and ATRX/DAXX loss can be reliably detected in FNAs of pancreatic neuroendocrine tumors.

VandenBussche CJ, Allison DB, Graham MK, Charu V, Lennon AM, Wolfgang CL, Hruban RH, Heaphy CM.

Cancer Cytopathol. 2017 Jul;125(7):544-551. doi: 10.1002/cncy.21857. Epub 2017 Apr 3.

36.

Fine-needle aspiration of metastatic melanoma presenting as bilateral breast cysts.

Inouye CM, Cimino-Mathews A, Eisner D, Rosenthal DL, VandenBussche CJ.

Diagn Cytopathol. 2017 May;45(5):446-451. doi: 10.1002/dc.23666. Epub 2017 Mar 20.

PMID:
28322032
37.

Improved risk stratification for patients with high-grade urothelial carcinoma following application of the Paris System for Reporting Urinary Cytology.

Cowan ML, Rosenthal DL, VandenBussche CJ.

Cancer Cytopathol. 2017 Jun;125(6):427-434. doi: 10.1002/cncy.21843. Epub 2017 Mar 8.

38.

Mesenchymal neoplasms of the head and neck: a cytopathologic analysis on fine needle aspiration.

Lee J, Kazmi S, VandenBussche CJ, Ali SZ.

J Am Soc Cytopathol. 2017 May - Jun;6(3):105-113. doi: 10.1016/j.jasc.2017.03.001. Epub 2017 Mar 18.

PMID:
31043260
39.

The presence of neuroendocrine features generates a broad differential diagnosis in the fine-needle aspiration of bone and soft tissue neoplasms.

Allison DB, McCuiston A, VandenBussche CJ.

J Am Soc Cytopathol. 2017 Sep - Oct;6(5):185-193. doi: 10.1016/j.jasc.2017.06.001. Epub 2017 Jul 8.

PMID:
31043241
40.

The utility of bronchial brushings in the modern era of flexible bronchoscopy.

VandenBussche CJ, Yarmus L, Illei PB.

J Am Soc Cytopathol. 2017 Jan - Feb;6(1):1-7. doi: 10.1016/j.jasc.2016.09.001. Epub 2016 Oct 25.

PMID:
31042627
41.

Preinvasive and Invasive Cervical Adenocarcinoma: Preceding Low-Risk or Negative Pap Result Increases Time to Diagnosis.

Moukarzel LA, Angarita AM, VandenBussche C, Rositch A, Thompson CB, Fader AN, Levinson K.

J Low Genit Tract Dis. 2017 Apr;21(2):91-96. doi: 10.1097/LGT.0000000000000286.

42.

Pancreatic Cytopathology.

Collins JA, Ali SZ, VandenBussche CJ.

Surg Pathol Clin. 2016 Dec;9(4):661-676. doi: 10.1016/j.path.2016.05.009. Epub 2016 Oct 12. Review.

PMID:
27926365
43.

Serous Cystadenoma of the Pancreas: Potentials and Pitfalls of a Preoperative Cytopathologic Diagnosis.

Lilo MT, VandenBussche CJ, Allison DB, Lennon AM, Younes BK, Hruban RH, Wolfgang CL, Ali SZ.

Acta Cytol. 2017;61(1):27-33. doi: 10.1159/000452471. Epub 2016 Nov 26.

PMID:
27889754
44.

Multicentre validation of a microRNA-based assay for diagnosing indeterminate thyroid nodules utilising fine needle aspirate smears.

Lithwick-Yanai G, Dromi N, Shtabsky A, Morgenstern S, Strenov Y, Feinmesser M, Kravtsov V, Leon ME, Hajdúch M, Ali SZ, VandenBussche CJ, Zhang X, Leider-Trejo L, Zubkov A, Vorobyov S, Kushnir M, Goren Y, Tabak S, Kadosh E, Benjamin H, Schnitzer-Perlman T, Marmor H, Motin M, Lebanony D, Kredo-Russo S, Mitchell H, Noller M, Smith A, Dattner O, Ashkenazi K, Sanden M, Berlin KA, Bar D, Meiri E.

J Clin Pathol. 2017 Jun;70(6):500-507. doi: 10.1136/jclinpath-2016-204089. Epub 2016 Oct 26.

45.

High prevalence of TERT promoter mutations in micropapillary urothelial carcinoma.

Nguyen D, Taheri D, Springer S, Cowan M, Guner G, Mendoza Rodriguez MA, Wang Y, Kinde I, VandenBussche CJ, Olson MT, Ricardo BF, Cunha I, Fujita K, Ertoy D, Kinzler KW, Bivalacqua TJ, Papadopoulos N, Vogelstein B, Netto GJ.

Virchows Arch. 2016 Oct;469(4):427-34. doi: 10.1007/s00428-016-2001-2. Epub 2016 Aug 12.

46.

Reflex Estrogen Receptor (ER) and Progesterone Receptor (PR) Analysis of Ductal Carcinoma In Situ (DCIS) in Breast Needle Core Biopsy Specimens: An Unnecessary Exercise That Costs the United States $35 Million/y.

VandenBussche CJ, Cimino-Mathews A, Park BH, Emens LA, Tsangaris TN, Argani P.

Am J Surg Pathol. 2016 Aug;40(8):1090-9. doi: 10.1097/PAS.0000000000000674.

PMID:
27299796
47.

Analytical validity of a microRNA-based assay for diagnosing indeterminate thyroid FNA smears from routinely prepared cytology slides.

Benjamin H, Schnitzer-Perlman T, Shtabsky A, VandenBussche CJ, Ali SZ, Kolar Z, Pagni F; Rosetta Genomics Group, Bar D, Meiri E.

Cancer Cytopathol. 2016 Oct;124(10):711-721. doi: 10.1002/cncy.21731. Epub 2016 May 25.

48.

A review of the Paris system for reporting urinary cytology.

VandenBussche CJ.

Cytopathology. 2016 Jun;27(3):153-6. doi: 10.1111/cyt.12345. Review.

PMID:
27221750
49.

Morphologists overestimate the nuclear-to-cytoplasmic ratio.

Zhang ML, Guo AX, VandenBussche CJ.

Cancer Cytopathol. 2016 Sep;124(9):669-77. doi: 10.1002/cncy.21735. Epub 2016 May 9.

50.

The cytomorphological features of low-grade urothelial neoplasms vary by specimen type.

Zhang ML, Rosenthal DL, VandenBussche CJ.

Cancer Cytopathol. 2016 Aug;124(8):552-64. doi: 10.1002/cncy.21716. Epub 2016 Mar 28.

Supplemental Content

Loading ...
Support Center